Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-23-013496

Chief Operating Officer acquired 430,749 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2023-02-23 Grant or award : show line 1 in the form +36,722 36,722 D
2023-02-23 Grant or award : show line 2 in the form +394,027 394,027 I

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-23 Grant or award : show line 3 in the form Employee Stock Option (right to buy) +10,767 10,767 D
2023-02-23 Grant or award : show line 4 in the form Employee Stock Option (right to buy) +2,827 2,827 D
2023-02-23 Grant or award : show line 5 in the form Employee Stock Option (right to buy) +75,620 75,620 D
Loading xslF345X03/doc4.xml…